I Farmaci Biologici in Nefrologia

I Farmaci Biologici in Nefrologia

Abstract non disponibile

Bibliographic Details
Main Authors:	Roberta Fenoglio, Dario Roccatello
Format:	Article
Language:	Italian
Published:	AboutScience Srl 2015-11-01
Series:	Giornale di Clinica Nefrologia e Dialisi
Subjects:	Biologic drugs Anti-CD20 monoclonal antibody Rituximab Therapy of glomerulonephritis
Online Access:	https://journals.aboutscience.eu/index.php/gcnd/article/view/831

Similar Items

Structural and functional comparability study of anti-CD20 monoclonal antibody with reference product
by: Singh SK, et al.
Published: (2018-11-01)

Refractory pemphigus vulgaris successfully treated with ofatumumab
by: Daniel M. Klufas, MD, et al.
Published: (2020-08-01)

Rituximab Therapy for Treatment of Pemphigus in Southeast Asians
by: Kanokrungsee S, et al.
Published: (2021-04-01)

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
by: Sonia Boyer-Suavet, et al.
Published: (2020-01-01)

Novel applications of Rituximab in dermatological disorders
by: Prasan R Bhandari, et al.
Published: (2014-01-01)

Disseminated Enteroviral Infection Associated with Obinutuzumab
by: Claire Dendle, et al.
Published: (2015-09-01)

Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy
by: Gabrielle Benesh, BS, et al.
Published: (2021-10-01)

The beginning of the new era of monoclonal antibodies biosimilars use in oncology:current international guidelines and the results of clinical trial of the first Russian rituximab biosimilar in patients with B-cell non-Hodgkin’s lymphoma
by: K D Kaplanov, et al.
Published: (2014-06-01)

Rituximab treatment of rheumatoid arthritis: new evidence
by: E L Nasonov, et al.
Published: (2009-06-01)

17p deletion strongly influences rituximab elimination in chronic lymphocytic leukemia
by: Cristina Bagacean, et al.
Published: (2019-01-01)

Rituximab Therapy for Primary Membranous Nephropathy in a Chinese Cohort
by: Shuang Gao, et al.
Published: (2021-05-01)

Radiolabeling and biodistribution of monoclonal antibody (MAb) anti-CD20 with iodine-131
by: Akinkunmi Ganiyu Akanji, et al.
Published: (2005-10-01)

Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders
by: Celine Kaegi, et al.
Published: (2019-09-01)

Modern view on treatment of membranous nephropathy
by: Irina N. Bobkova, et al.
Published: (2020-07-01)

Rituximab: historia, farmacología y perspectivas Rituximab: history, pharmacology and perspectives
by: Edgardo E. Espinosa Estrada, et al.
Published: (2010-12-01)

"Estudo de marcação com Iodo-131 de anticorpo monoclonal anti-CD20 usado na terapia de linfoma não-Hodgkin"
by: Akinkunmi Ganiyu Akanji
Published: (2006)

"Estudo de marcação com Iodo-131 de anticorpo monoclonal anti-CD20 usado na terapia de linfoma não-Hodgkin"
by: Akanji, Akinkunmi Ganiyu
Published: (2006)

Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence
by: Masoud Etemadifar, et al.
Published: (2017-01-01)

In vivo- und in vitro-Komplementaktivierung durch den monoklonalen CD20-Antikörper Rituximab bei der Behandlung von Non-Hodgkin-Lymphomen
by: Gerecke, Christian
Published: (2006)

The clinical development of obinutuzumab for the treatment of follicular lymphoma
by: Ma B, et al.
Published: (2017-04-01)

Atypical COVID-19 dynamics in a patient with mantle cell lymphoma exposed to rituximab
by: Gianpaolo Marcacci, et al.
Published: (2021-06-01)

Monoclonal Gammopathy of Renal Significance: Clinical and Histological Efficacy of a Bortezomib-Based Regimen
by: Giacomo Quattrocchio, et al.
Published: (2020-12-01)

Farmaci e bioetica in nefrologia
by: Mario Timio, et al.
Published: (2016-02-01)

Uso do rituximabe para o tratamento da plaquetopenia do lúpus eritematoso sistêmico: eficácia clínica e efeito nas moléculas de co-estimulação Use of rituximab for the treatment of systemic lupus erythematosus' thrombocytopenia: clinical efficacy and costimulatory molecules effect
by: Mittermayer B. Santiago, et al.
Published: (2006-04-01)

An update on newer monoclonal antibodies in lymphoma therapy
by: Subhashini Archana Kadavakolan, et al.
Published: (2016-01-01)

Rituximab (Mabthera), a new approach for the treatment of rheumatoid arthritis. A systematic review
by: Eduardo Finger, et al.
Published: (2007-12-01)

Rituximab Therapy in Pulmonary Alveolar Proteinosis: A Rare Case Report
by: Fatemeh Aghaei Meybodi, et al.
Published: (2018-04-01)

Production and Characterization of New Anti-Human CD20 Monoclonal Antibody
by: Mahdi Fasihi-Ramandi, et al.
Published: (2015-10-01)

The role of EGR-1 and calcium influx in the antitumor activity of anti-CD20 monoclonal antibodies
by: Spasevska, Ivana
Published: (2017)

Immunotherapy for B-cell lymphoma: current status and prospective advances
by: Nurit eHollander
Published: (2012-01-01)

10-year personal experience of rituximab use in nephrological patients
by: D.D. Ivanov, et al.
Published: (2020-03-01)

Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody Therapy
by: Timothy M. Pierpont, et al.
Published: (2018-06-01)

Macroglobulinemia de Waldenström - remissão completa após tratamento com rituximabe Successful outcome in Waldenström's macroglobulinemia treated with rituximab
by: Flavia C. F. Pimenta, et al.
Published: (2008-10-01)

CD20 mAb-Mediated Complement Dependent Cytotoxicity of Tumor Cells is Enhanced by Blocking the Action of Factor I
by: Margaret A. Lindorfer, et al.
Published: (2013-11-01)

Inebilizumab for treatment of neuromyelitis optica spectrum disorder in patients with prior rituximab use from the N-MOmentum Study
by: Cimbora, D., et al.
Published: (2022)

Application of anti-CD20 monoclonal antibodies in the treatment of lymphoproliferative diseases
by: Pejčić Ivica, et al.
Published: (2009-01-01)

Obinutuzumab activates FcγRI more potently than other anti-CD20 antibodies in chronic lymphocytic leukemia (CLL)
by: Shlomo Elias, et al.
Published: (2018-06-01)

Co-transplantation of neonatal porcine islets with Sertoli cells combined with short-term monoclonal antibody therapy in preventing neonatal porcine islet xenograft rejection
by: Ramji, Qahir A.
Published: (2009)

Type I allergic reaction to rituximab upon first lifetime exposure: a case report
by: V. Polito, et al.
Published: (2020-06-01)

Pemphigus: Current and Future Therapeutic Strategies
by: Dario Didona, et al.
Published: (2019-06-01)